{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:41:24Z","timestamp":1791484884894,"version":"4.3.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02394-4","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:19:42Z","timestamp":1663917582000},"page":"643-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center"],"prefix":"10.1007","volume":"315","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-3907","authenticated-orcid":false,"given":"Grace Y.","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8318-4727","authenticated-orcid":false,"given":"Arlene M.","family":"Ruiz de Luzuriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2394_CR1","doi-asserted-by":"publisher","DOI":"10.5348\/100004D02MA2021ED","author":"MB Abdel-Naser","year":"2021","unstructured":"Abdel-Naser MB (2021) COVID-19 pandemic and teledermatology in low-income regions. Edorium J Dermatol. https:\/\/doi.org\/10.5348\/100004D02MA2021ED","journal-title":"Edorium J Dermatol"},{"key":"2394_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40834-020-00114-9","volume":"5","author":"J Aly","year":"2020","unstructured":"Aly J, Haeger KO, Christy AY, Johnson AM (2020) Contraception access during the COVID-19 pandemic. Contracept Reprod Med 5:17. https:\/\/doi.org\/10.1186\/s40834-020-00114-9","journal-title":"Contracept Reprod Med"},{"key":"2394_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamadermatol.2019.4818","volume":"156","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J (2020) Association of race\/ethnicity and sex with differences in health care use and treatment for acne. JAMA Dermatol 156:312\u2013319. https:\/\/doi.org\/10.1001\/jamadermatol.2019.4818","journal-title":"JAMA Dermatol"},{"key":"2394_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210445","volume":"14","author":"A Charrow","year":"2019","unstructured":"Charrow A, Xia FD, Lu J, Waul M, Joyce C, Mostaghimi A (2019) Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era. PLoS\u00a0One 14:e0210445. https:\/\/doi.org\/10.1371\/journal.pone.0210445","journal-title":"PLoS\u00a0One"},{"key":"2394_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1067\/S0190-9622(03)01584-6","volume":"49","author":"AB Fleischer","year":"2003","unstructured":"Fleischer AB, Simpson JK, McMichael A, Feldman SR (2003) Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States? J Am Acad Dermatol 49:662\u2013666. https:\/\/doi.org\/10.1067\/S0190-9622(03)01584-6","journal-title":"J Am Acad Dermatol"},{"key":"2394_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/JDN.0000000000000595","volume":"13","author":"S Kane","year":"2021","unstructured":"Kane S, Admani S (2021) COVID-19 pandemic leading to the accelerated development of a virtual health model for isotretinoin. J Dermatol Nurses Assoc 13:54\u201357. https:\/\/doi.org\/10.1097\/JDN.0000000000000595","journal-title":"J Dermatol Nurses Assoc"},{"key":"2394_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14411","volume":"33","author":"JT Pathoulas","year":"2020","unstructured":"Pathoulas JT, Farah RS, Fiessinger L, Mansh M (2020) An opportunity for improvement: iPLEDGE policy changes during the coronavirus pandemic. Dermatol Ther 33:e14411. https:\/\/doi.org\/10.1111\/dth.14411","journal-title":"Dermatol Ther"},{"key":"2394_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jaad.2010.09.017","volume":"65","author":"J Shin","year":"2011","unstructured":"Shin J, Cheetham TC, Wong L, Niu F, Kass E, Yoshinaga MA, Sorel M, McCombs JS, Sidney S (2011) The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol 65:1117\u20131125. https:\/\/doi.org\/10.1016\/j.jaad.2010.09.017","journal-title":"J Am Acad Dermatol"},{"key":"2394_CR9","unstructured":"U.S. Food and Drug Administration (Updated March 22, 2020) Coronavirus (COVID-19) update: FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency. Accessed Dec 27, 2021. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-provides-update-patient-access-certain-rems-drugs-during-covid-19"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02394-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02394-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02394-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T12:08:48Z","timestamp":1678968528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02394-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":9,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["2394"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02394-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors GD and AR declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}